{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:28:17Z","timestamp":1773224897732,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The study aim was to evaluate the estimated glomerular filtration rate (eGFR), its association with clinical disease and its predictive ability with respect to mortality in SSc patients from the European Scleroderma Trials and Research Group (EUSTAR) database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>SSc patients from the EUSTAR database who had items required for the calculation of eGFR at a baseline visit and a second follow-up visit available were included. A cut-off eGFR value of 60\u2009ml\/min was chosen for all SSc patients, and 30\u2009ml\/min for those with scleroderma renal crisis (SRC). Cox regression and competing risk analysis were performed to evaluate the use of eGFR as a predictive factor of mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 3650 SSc patients were included in this study. The median serum level of creatinine and the mean of eGFR were 0.8\u2009mg\/dl (interquartile range = 0.6\u20130.9) and 86.6\u2009\u00b1\u200923.7\u2009ml\/min, respectively. The eGFR was significantly lower in patients with pulmonary hypertension. Overall survival (OS) was significantly reduced in SSc patients with eGFR\u2009&amp;lt;\u200960\u2009ml\/min compared with patients with eGFR\u2009\u2265\u200960\u2009ml\/min [OS at 5\u2009years 0.763 (95% CI: 0.700, 0.814) vs 0.903 (95% CI: 0.883, 0.919; P\u2009&amp;lt;\u20090.001)]. In multivariable analysis, OS was associated with male gender (P\u2009&amp;lt;\u20090.01), systolic pulmonary arterial pressure (sPAP) (P\u2009&amp;lt;\u20090.001) and eGFR (P\u2009&amp;lt;\u20090.001). The cumulative incidence of deaths due to SSc was associated with increased sPAP (P\u2009&amp;lt;\u20090.001) and reduced eGFR (P\u2009&amp;lt;\u20090.05). The OS at 5\u2009years of 53 SRC patients was not significantly different between SSc patients with eGFR\u2009&amp;gt;\u200930\u2009ml\/min and those with eGFR\u2009&amp;lt;30\u2009ml\/min.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>eGFR represents a predictive risk factor for overall survival in SSc. The eGFR, however, does not represent a risk factor for death in SRC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab302","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T20:24:33Z","timestamp":1616531073000},"page":"213-222","source":"Crossref","is-referenced-by-count":7,"title":["Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database"],"prefix":"10.1093","volume":"61","author":[{"given":"Antonietta","family":"Gigante","sequence":"first","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-7422","authenticated-orcid":false,"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Alunni Fegatelli","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando\u00a0","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, Universit\u00e0 Politecnica delle Marche, University of Ancona, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Leodori","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Coleiro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mater Dei Hospital, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-1336","authenticated-orcid":false,"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Clinical Immunology Department, Humanitas Clinical and Research Center\u2013IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Hospital\u2014Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jose","family":"Alegre-Sancho","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario Doctor Peset, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa e Cattedra di Reumatolog\u00eda, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E","family":"Carreira","sequence":"additional","affiliation":[{"name":"Servicio de Reumatolog\u00eda, Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra\u00a0","family":"Balbir-Gurman","sequence":"additional","affiliation":[{"name":"B. Shine Rheumatology Unit, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-4983","authenticated-orcid":false,"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Clinic Schleswig-Holstein, L\u00fcbeck, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Air\u00f2","sequence":"additional","affiliation":[{"name":"UOC Reumatolog\u00eda ed Immunologia Clinica, Spedali Civili di Brescia, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg\u00a0","family":"Distler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital, Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-8093","authenticated-orcid":false,"given":"Edoardo","family":"Rosato","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the EUSTAR collaborators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"2022010903445340200_keab302-B1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology"},{"key":"2022010903445340200_keab302-B2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0b013e3283588dcf","article-title":"Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management","volume":"24","author":"Shanmugam","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2022010903445340200_keab302-B3","doi-asserted-by":"crossref","first-page":"538589","DOI":"10.1155\/2010\/538589","article-title":"Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy","volume":"2010","author":"Shanmugam","year":"2010","journal-title":"Int J Rheumatol"},{"key":"2022010903445340200_keab302-B4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009740802629424","article-title":"Renal function is mostly preserved in patients with systemic sclerosis","volume":"38","author":"Scheja","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"2022010903445340200_keab302-B5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2022010903445340200_keab302-B6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022010903445340200_keab302-B7","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022010903445340200_keab302-B8","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2022010903445340200_keab302-B9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022010903445340200_keab302-B10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: definition and classification of CKD","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2022010903445340200_keab302-B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3899\/jrheum.180582","article-title":"Scleroderma renal crisis: risk factors for an increasingly rare organ complication","volume":"47","author":"Moinzadeh","year":"2020","journal-title":"J Rheumatol"},{"key":"2022010903445340200_keab302-B12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","article-title":"ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis\u2014a EUSTAR analysis","volume":"22","author":"B\u00fctikofer","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022010903445340200_keab302-B13","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/ndt\/gfq861","article-title":"End-stage kidney disease due to scleroderma\u2014outcomes in 127 consecutive ANZDATA registry cases","volume":"26","author":"Siva","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2022010903445340200_keab302-B14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","article-title":"Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment","volume":"42","author":"Kingdon","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2022010903445340200_keab302-B15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/rheumatology\/kes049","article-title":"Evaluation of Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in scleroderma patients","volume":"51","author":"Gigante","year":"2012","journal-title":"Rheumatology"},{"key":"2022010903445340200_keab302-B16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-010-1389-3","article-title":"Renal disease in systemic sclerosis with normal serum creatinine","volume":"29","author":"Mohamed","year":"2010","journal-title":"Clin Rheumatol"},{"key":"2022010903445340200_keab302-B17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000489740","article-title":"Prognostic factors of renal involvement in systemic sclerosis","volume":"43","author":"Rosato","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"2022010903445340200_keab302-B18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.61.8.682","article-title":"Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement","volume":"61","author":"Livi","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2022010903445340200_keab302-B19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3899\/jrheum.190165","article-title":"Renal parenchymal thickness in patients with systemic sclerosis is related to intrarenal hemodynamic variables and Raynaud renal phenomenon","volume":"47","author":"Gigante","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"2022010903445340200_keab302-B20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma related pulmonary arterial hypertension","volume":"182","author":"Campo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2022010903445340200_keab302-B21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3899\/jrheum.191101","article-title":"The renal resistive index, a new biomarker for the follow up of vascular modifications in systemic sclerosis","volume":"48","author":"Gigante","year":"2021","journal-title":"J Rheumatol"},{"key":"2022010903445340200_keab302-B22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000487199","article-title":"Pulmonary arterial hypertension and the kidney: getting to the heart of the matter","volume":"47","author":"Kazory","year":"2018","journal-title":"Am J Nephrol"},{"key":"2022010903445340200_keab302-B23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/keu450","article-title":"Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population","volume":"54","author":"Hachulla","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2022010903445340200_keab302-B24","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022010903445340200_keab302-B25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"2022010903445340200_keab302-B26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","article-title":"Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022010903445340200_keab302-B27","doi-asserted-by":"crossref","first-page":"e1728","DOI":"10.1097\/MD.0000000000001728","article-title":"Registry of the Spanish Network for Systemic Sclerosis: survival, prognostic factors, and causes of death","volume":"94","author":"Sime\u00f3n-Aznar","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2022010903445340200_keab302-B28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022010903445340200_keab302-B29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/BOR.0000000000000604","article-title":"Management of scleroderma renal crisis","volume":"31","author":"Nagaraja","year":"2019","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab302\/37903562\/keab302.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/1\/213\/41929185\/keab302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/1\/213\/41929185\/keab302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T03:46:22Z","timestamp":1641699982000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/1\/213\/6189034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3,26]]},"published-print":{"date-parts":[[2021,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab302","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,3,26]]}}}